| 发明名称 |
USE OF LINAGLIPTIN IN CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY |
| 摘要 |
The present invention relates to the DPP-4 inhibitor linagliptin for use in cardio- and/or renoprotective therapy, including in diabetic or non- diabetic patients at high vascular risk. |
| 申请公布号 |
WO2014140284(A1) |
申请公布日期 |
2014.09.18 |
| 申请号 |
WO2014EP55113 |
申请日期 |
2014.03.14 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
JOHANSEN, ODD-ERIK;VON EYNATTEN, MAXIMILIAN;KLEIN, THOMAS;WOERLE, HANS-JUERGEN |
| 分类号 |
A61K31/522;A61K31/155;A61K31/4184;A61K38/28;A61K45/06;A61P3/10;A61P9/00;A61P9/10;A61P13/12 |
主分类号 |
A61K31/522 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
